Hangzhou AGS Medtech Co (SHSE:688581) Change In Payables And Accrued Expense : ¥0.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co Change In Payables And Accrued Expense?

Hangzhou AGS Medtech Co's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2024 was ¥0.0 Mil. It means Hangzhou AGS Medtech Co's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Jun. 2024 .

Hangzhou AGS Medtech Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0.0 Mil. It means Hangzhou AGS Medtech Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Hangzhou AGS Medtech Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Hangzhou AGS Medtech Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co Change In Payables And Accrued Expense Chart

Hangzhou AGS Medtech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Hangzhou AGS Medtech Co Quarterly Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial												-	-	-	-	-

Hangzhou AGS Medtech Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Hangzhou AGS Medtech Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou AGS Medtech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106

Website

http://www.bioags.com

Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Executives

Zhang Cheng

Director

Hangzhou AGS Medtech Co Headlines

No Headlines